Literature DB >> 14258615

NARCOTIC ANTAGONISTS IN THE BENZOMORPHAN SERIES. RESPIRATORY, CARDIOVASCULAR AND BEHAVIORAL EFFECTS IN DOGS.

L S HARRIS.   

Abstract

Entities:  

Keywords:  ANALGESICS AND ANTIPYRETICS; BEHAVIOR, ANIMAL; CARDIOVASCULAR SYSTEM; DOGS; EXPERIMENTAL LAB STUDY; NALORPHINE; PHARMACOLOGY; RESPIRATION

Mesh：

Substances：

Year:  1964        PMID： 14258615     DOI： 10.1007/BF00246889

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol


× No keyword cloud information.
  8 in total

1.  STUDIES ON THE HUMAN ADDICTION LIABILITY OF 2'-HYDROXY-5-9-DIMETHYL-2-(3,3-DIMETHYLALLYL)-6,7-BENZOMORPHAN (WIN 20,228): A WEAK NARCOTIC ANTAGONIST.

Authors:  H F FRASER; D E ROSENBERG
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

2.  STUDIES OF ANALGESIC DRUGS. VIII. A NARCOTIC ANTAGONIST ANALGESIC WITHOUT PSYCHOTOMIMETIC EFFECTS.

Authors:  A S KEATS; J TELFORD
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

3.  SOME NARCOTIC ANTAGONISTS IN THE BENZOMORPHAN SERIES.

Authors:  L S HARRIS; A K PIERSON
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

4.  Narcotic antagonists as analgesics.

Authors:  S ARCHER; N F ALBERTSON; L S HARRIS; A K PIERSON; J G BIRD; A S KEATS; J TELFORD; C N PAPADOPOULOS
Journal:  Science       Date:  1962-08-17       Impact factor: 47.728

5.  Narcotic--narcotic antagonist mixtures.

Authors:  J TELFORD; A S KEATS
Journal:  Anesthesiology       Date:  1961 May-Jun       Impact factor: 7.892

6.  Nalorphine, a potent analgesic in man.

Authors:  A S KEATS; J TELFORD
Journal:  J Pharmacol Exp Ther       Date:  1956-06       Impact factor: 4.030

7.  The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man.

Authors:  L LASAGNA; H K BEECHER
Journal:  J Pharmacol Exp Ther       Date:  1954-11       Impact factor: 4.030

8.  The effect of nalorphine on the respiration of dogs anesthetized with pentobarbital sodium.

Authors:  A VIVANTE; F F KAO; J BELFORD
Journal:  J Pharmacol Exp Ther       Date:  1954-08       Impact factor: 4.030
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.